心脏骤停后接受ECPR患者的死亡风险因素:临床预后预测模型的开发与验证
该前瞻性多中心研究基于中国61家医院CSECLS登记数据库,纳入2017年1月至2022年5月接受ECPR的990例心脏骤停患者。以2021年10月前符合纳入标准的351例患者(其中227例,64.8%院内死亡)用Cox回归开发预测模型,2021年10月后68例进行外部验证。多因素分析显示脑血管病史、无脉电活动(PEA)/心静止、较高乳酸为死亡风险因素,年龄45-60岁、较高pH及ECPR期间使用主动脉内球囊反搏(IABP)为保护因素。模型内部bootstrap重采样验证C统计量0.70、校准良好(GOF卡方=10.4,p=0.50),外部验证C统计量0.65、校准良好(GOF卡方=6.1,p=0.809)。作者认为这些因素可用于风险预测,从而改善这一资源密集型治疗的患者管理与治疗选择。
要点
- 351例接受ECPR的心脏骤停患者中227例(64.8%)在出院前死亡。
- 多因素分析提示脑血管病史、PEA/心静止、较高乳酸为院内死亡风险因素。
- 年龄45-60岁、较高pH、ECPR期间使用IABP为院内死亡的保护因素。
- 模型内部验证C统计量0.70(GOF卡方=10.4,p=0.50),外部验证C统计量0.65(GOF卡方=6.1,p=0.809)。
- 作者认为上述因素可用于ECPR患者风险预测,以改善患者管理与治疗选择。
适用人群与场景
- 2017年1月至2022年5月在中国61家医院CSECLS登记数据库中接受ECPR的心脏骤停患者990例(前瞻性多中心研究)。
- 建模队列为2021年10月前符合纳入标准的351例患者,外部验证队列为2021年10月后68例患者。
研究设计与关键结果
- 研究设计:前瞻性、多中心研究,收集中国61家医院2017年1月至2022年5月接受ECPR的990例心脏骤停患者,采用Cox回归开发临床预测模型并用外部数据验证。
- 建模队列351例接受ECPR的心脏骤停患者中,227例(64.8%)在出院前死亡。
- 多因素分析提示脑血管病史、无脉电活动(PEA)/心静止、较高乳酸为死亡风险因素。
- 多因素分析提示年龄45-60岁、较高pH、ECPR期间使用主动脉内球囊反搏(IABP)为保护因素。
- 内部bootstrap重采样验证显示中等区分度,尤其在ECPR后早期,全队列C统计量0.70,校准良好(GOF卡方=10.4,p=0.50)。
- 外部验证队列区分度尚可,C统计量0.65,校准良好(GOF卡方=6.1,p=0.809),表明模型可在较宽概率范围内预测院内死亡。
证据类型、等级与局限
- 证据类型:前瞻性、多中心研究,基于CSECLS登记数据库开发并外部验证临床预后预测模型。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脑血管病史、较高乳酸、PEA或心静止、年龄45-60岁、较高pH及使用IABP等识别出的因素可用于风险预测,从而改善接受ECPR这一资源密集型治疗患者的管理与治疗选择。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous studies have shown an increasing trend of extracorporeal cardiopulmonary resuscitation (ECPR) use in patients with cardiac arrest (CA). Although ECPR have been found to reduce mortality in patients with CA compared with conventional cardiopulmonary resuscitation (CCPR), the mortality remains high. This study was designed to identify the potential mortality risk factors for ECPR patients for further optimization of patient management and treatment selection.
METHODS: We conducted a prospective, multicentre study collecting 990 CA patients undergoing ECPR in 61 hospitals in China from January 2017 to May 2022 in CSECLS registry database. A clinical prediction model was developed using cox regression and validated with external data.
RESULTS: The data of 351 patients meeting the inclusion criteria before October 2021 was used to develop a prediction model and that of 68 patients after October 2021 for validation. Of the 351 patients with CA treated with ECPR, 227 (64.8%) patients died before hospital discharge. Multivariate analysis suggested that a medical history of cerebrovascular diseases, pulseless electrical activity (PEA)/asystole and higher Lactate (Lac) were risk factors for mortality while aged 45-60, higher pH and intra-aortic balloon pump (IABP) during ECPR have protective effects. Internal validation by bootstrap resampling was subsequently used to evaluate the stability of the model, showing moderate discrimination, especially in the early stage following ECPR, with a C statistic of 0.70 and adequate calibration with GOF chi-square = 10.4 (p = 0.50) for the entire cohort. Fair discrimination with c statistic of 0.65 and good calibration (GOF chi-square = 6.1, p = 0.809) in the external validation cohort demonstrating the model's ability to predict in-hospital death across a wide range of probabilities.
CONCLUSION: Risk factors have been identified among ECPR patients including a history of cerebrovascular diseases, higher Lac and presence of PEA or asystole. While factor such as age 45-60, higher pH and use of IABP have been found protective against in-hospital mortality. These factors can be used for risk prediction, thereby improving the management and treatment selection of patients for this resource-intensive therapy.
参考来源
- Li Z, Gao J, Wang J, et al. Mortality risk factors in patients receiving ECPR after cardiac arrest: Development and validation of a clinical prognostic prediction model. Am J Emerg Med. 2023. PMID: 38056056. doi:10.1016/j.ajem.2023.11.048
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。